NR565 ADVANCED PHARMACOLOGY
MIDTERM EXAM STUDY GUIDE EXAM
QUESTIONS WITH CORRECT
ANSWERS GRADED A+ FOR 2025-
2026 ASSURED EXCEL!!
DrugswthatwAPRNswcanwprescribew-wwCORRECTwANSWERSSchedulew3-5wdrugs
DeterminedwbywStatewBoardswofwNursing,wMedicine,wandwPharmacyw-
wwCORRECTwANSWERSPrescriptivewauthoritywregulation
Leadswtowfewerwtreatmentwoptionswforwpatients,wrequiringwthemwtowfindwproviderswwithwauthorityw-
wwCORRECTwANSWERSLimitedwprescriptivewauthoritywimpact
Understandingwprescribedwdrugs,wtheirweffects,wcontraindications,wandwensuringwcorrectwdosagesw-
wwCORRECTwANSWERSKeywresponsibilitieswofwprescribing
AcronymwforwCYP450wenzymewinducers:wBarbiturates,wSt.wJohn'swWort,wCarbamazepine,wRifampin,wAlcoh
ol,wPhenytoin,wGriseofulvin,wPhenobarbital,wSulfonylureasw-
wwCORRECTwANSWERSBSCRAPwGPSwIncudeswRage
Amountwofwactivewdrugwreachingwsystemicwcirculationwfromwadministrationwsitew-
wwCORRECTwANSWERSBioavailability
Includewforgetfulness,wlackwofwplanning,wcost,wdissatisfaction,wandwalteredwdosingw-
wwCORRECTwANSWERSReasonswforwmedicationwnonadherence
Absorptionwiswslowwinwneonateswduewtowlowwmusclewbloodwflow;wabsorptionwbecomeswrapidwinwearlywinfa
ncyw-wwCORRECTwANSWERSIMwadministrationwinwneonateswandwinfants
, Gastricwemptyingwtimewiswprolongedwandwirregularwinwearlywinfancy,waffectingwdrugwabsorptionw-
wwCORRECTwANSWERSOralwadministrationwinwneonates/infants
Basedwonwbodywsurfacewareaw(BSA)wcalculationw-
wwCORRECTwANSWERSDosagewdeterminationwforwpediatricwpatients
Stepswincludewdefiningwthewproblem,wsettingwtherapeuticwobjectives,wchoosingwtreatment,wverifyingwitsws
uitability,wstartingwtreatment,wgivingwinformation,wandwmonitoringwtreatmentw-
wwCORRECTwANSWERSGuidingwprincipleswforwprescribers
ExampleswincludewValproate,wIsoniazid,wSulfonamides,wAmiodarone,wChloramphenicol,wKetoconazole,wGr
apefruitwjuice,wQuinidinew-wwCORRECTwANSWERSCYP450winhibitors
Basiswforwprescribingwdecisions,wconsideringwdrugwinteractionswandweffectswonwtargetwreceptorsw-
wwCORRECTwANSWERSPharmacokineticswandwpharmacodynamics
Toolwidentifyingwinappropriatewmedicationwusewinwolderwadults,wcautioningwagainstwcertainwdrugswandwint
eractionsw-wwCORRECTwANSWERSBeer'swCriteria
Includewadversewdrugwevents,wincreasedwhealthcarewinteractions,wcognitivewimpairment,wreducedwadhere
nce,wfalls,wandwmortalityw-wwCORRECTwANSWERSImpactswofwpolypharmacy
Theywdecreasewmedicationwmetabolismw-wwCORRECTwANSWERSCYP450winhibitorswfunction
Maywcausewtoxicitywifwenzymeswarewinactiveworwineffectivenesswifwenzymeswarewoveractivew-
wwCORRECTwANSWERSCYP450winhibitorswconsequences
OccurswwhenwCYP2D6walleleswhavewinactivatingwmutations,wleadingwtowenzymewsynthesiswwithwimpairedw
orwnowactivityw-wwCORRECTwANSWERSPoorwmetabolismwphenotype
Ensureswsafety,wefficiency,wandwsecuritywofwhumanwandwveterinarywdrugs,wbiologicalwproducts,wandwmedi
calwdevicesw-wwCORRECTwANSWERSUSwFDAwregulation
MIDTERM EXAM STUDY GUIDE EXAM
QUESTIONS WITH CORRECT
ANSWERS GRADED A+ FOR 2025-
2026 ASSURED EXCEL!!
DrugswthatwAPRNswcanwprescribew-wwCORRECTwANSWERSSchedulew3-5wdrugs
DeterminedwbywStatewBoardswofwNursing,wMedicine,wandwPharmacyw-
wwCORRECTwANSWERSPrescriptivewauthoritywregulation
Leadswtowfewerwtreatmentwoptionswforwpatients,wrequiringwthemwtowfindwproviderswwithwauthorityw-
wwCORRECTwANSWERSLimitedwprescriptivewauthoritywimpact
Understandingwprescribedwdrugs,wtheirweffects,wcontraindications,wandwensuringwcorrectwdosagesw-
wwCORRECTwANSWERSKeywresponsibilitieswofwprescribing
AcronymwforwCYP450wenzymewinducers:wBarbiturates,wSt.wJohn'swWort,wCarbamazepine,wRifampin,wAlcoh
ol,wPhenytoin,wGriseofulvin,wPhenobarbital,wSulfonylureasw-
wwCORRECTwANSWERSBSCRAPwGPSwIncudeswRage
Amountwofwactivewdrugwreachingwsystemicwcirculationwfromwadministrationwsitew-
wwCORRECTwANSWERSBioavailability
Includewforgetfulness,wlackwofwplanning,wcost,wdissatisfaction,wandwalteredwdosingw-
wwCORRECTwANSWERSReasonswforwmedicationwnonadherence
Absorptionwiswslowwinwneonateswduewtowlowwmusclewbloodwflow;wabsorptionwbecomeswrapidwinwearlywinfa
ncyw-wwCORRECTwANSWERSIMwadministrationwinwneonateswandwinfants
, Gastricwemptyingwtimewiswprolongedwandwirregularwinwearlywinfancy,waffectingwdrugwabsorptionw-
wwCORRECTwANSWERSOralwadministrationwinwneonates/infants
Basedwonwbodywsurfacewareaw(BSA)wcalculationw-
wwCORRECTwANSWERSDosagewdeterminationwforwpediatricwpatients
Stepswincludewdefiningwthewproblem,wsettingwtherapeuticwobjectives,wchoosingwtreatment,wverifyingwitsws
uitability,wstartingwtreatment,wgivingwinformation,wandwmonitoringwtreatmentw-
wwCORRECTwANSWERSGuidingwprincipleswforwprescribers
ExampleswincludewValproate,wIsoniazid,wSulfonamides,wAmiodarone,wChloramphenicol,wKetoconazole,wGr
apefruitwjuice,wQuinidinew-wwCORRECTwANSWERSCYP450winhibitors
Basiswforwprescribingwdecisions,wconsideringwdrugwinteractionswandweffectswonwtargetwreceptorsw-
wwCORRECTwANSWERSPharmacokineticswandwpharmacodynamics
Toolwidentifyingwinappropriatewmedicationwusewinwolderwadults,wcautioningwagainstwcertainwdrugswandwint
eractionsw-wwCORRECTwANSWERSBeer'swCriteria
Includewadversewdrugwevents,wincreasedwhealthcarewinteractions,wcognitivewimpairment,wreducedwadhere
nce,wfalls,wandwmortalityw-wwCORRECTwANSWERSImpactswofwpolypharmacy
Theywdecreasewmedicationwmetabolismw-wwCORRECTwANSWERSCYP450winhibitorswfunction
Maywcausewtoxicitywifwenzymeswarewinactiveworwineffectivenesswifwenzymeswarewoveractivew-
wwCORRECTwANSWERSCYP450winhibitorswconsequences
OccurswwhenwCYP2D6walleleswhavewinactivatingwmutations,wleadingwtowenzymewsynthesiswwithwimpairedw
orwnowactivityw-wwCORRECTwANSWERSPoorwmetabolismwphenotype
Ensureswsafety,wefficiency,wandwsecuritywofwhumanwandwveterinarywdrugs,wbiologicalwproducts,wandwmedi
calwdevicesw-wwCORRECTwANSWERSUSwFDAwregulation